Transformation of cholera toxin B subunit-human proinsulin chimeric gene to edible mushroom (Pleurotus ostreatus) and evaluation of its presence and expression
Message:
Abstract:
Diabetes is a disease in which the body does not produce or properly utilize insulin. Although insulin is predominantly made in bacteria or yeast for commercial production, there is a burgeoning need for alternative systems in the production of insulin. In this regard, edible oyster mushroom was studied as host for the production of insulin. Therefore, a binary vector pCAMBIACTB-INS was constructed containing the cholera toxin B subunit fused with human proinsulin gene under the control of glyceraldehyde-3-phosphate dehydrogenase as homologous promoter. Then it introduced into gill tissue of edible oyster mushroom, Pleurotus ostreatus isolate Iran1649c, via Agrobacterium Tumefaciens strain GV3101 (OD600nm) and co-cultivated with P. ostreatus at 25 °C on selective medium containing hygromycin and cefotaxime. After confirming Putative transformants by PCR using gene specific primers, stable integration of the CTB-proinsulin fusion gene into P. ostreatus genome was confirmed by Southern blotting analysis. Also, the expression of transgene was confirmed by RT-PCR, ELISA and immunoblotting methods and in transgenic mycelia the recombinant CTB-proinsulin showed an expression level by 0.04% of total soluble protein. In conclusion successful expression of foreign genes in transgenic mushrooms is promising for development of biopharmaceutical in edible mushrooms.
medium containing hygromycin and cefotaxime. After confirming Putative transformants using PCR with specific primers, stable integration of the CTB-proinsulin fusion gene into P. ostreatus genome was confirmed by Southern blotting analysis. Also, the expression of transgene was confirmed by RT-PCR, ELISA and immunoblotting methods and in transgenic mycelia the recombinant CTB-proinsulin showed an expression level by 0.04% of total soluble protein. In conclusion successful expression of foreign genes in transgenic mushrooms is promising for development of biopharmaceutical in edible mushrooms.
Article Type:
Research/Original Article
Language:
Persian
Published:
Journal of Genetics, Volume:12 Issue:3, 2017
Page:
441
magiran.com/p1784792  
روش‌های دسترسی به متن این مطلب
اشتراک شخصی
در سایت عضو شوید و هزینه اشتراک یک‌ساله سایت به مبلغ 300,000ريال را پرداخت کنید. همزمان با برقراری دوره اشتراک بسته دانلود 100 مطلب نیز برای شما فعال خواهد شد!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی همه کاربران به متن مطالب خریداری نمایند!